In orthotopic 4T1 breast cancer models, this platform effectively blocked the Snail/TGF-β signaling pathway and reversed EMT by silencing Snail expression and eliminating M2 TAMs, ultimately achieving a TIR of 93.3% with no lung metastasis. Here, SNAI1 is linked to breast carcinoma.